March-Yagüe, A, Toledo, D, Díaz, A, Godoy, P, Pérez-Martínez, O, Pericas, C, Sanchez-Migallon, A, Chirlaque, MD, Ospina, J, Grau, M, Roig, F, Domínguez, A. Mpox in people living with and without HIV, including people on PrEP, during a multistate outbreak in Spain in 2022. Scientific Reports. 2026; 16(1)DOI:10.1038/s41598-026-37209-3. PMID:41714652. IF:3.900(Q1/2D).

Luquin, M, Lopez-Ariztegui, N, Castrillo, JCM, Manzanares, LL, Bataller, IS, Fernández, AK, Pastor, BV, Vila, BS, Sauco, MA, Mora, JP, González, JMA, Ruiz-Espiga, PJG, de Fàbregues, O, del Val, JL, Arillo, VC, Moreno, C, Ameijeiras, JB, Jiménez, IP, Ayuela, IT. Real-world data of opicapone in patients with Parkinson's disease experiencing motor fluctuations: the OPTIMO study. Frontiers in Neurology. 2026; 17DOI:10.3389/fneur.2026.1738500. PMID:41798821. IF:2.800(Q2/5D).

Benejam, B, McCarron, M, Carmona-Iragui, M, Dunne, P, Maure-Blesa, L, Altuna, M, Arranz, J, Barroeta, I, Bejanin, A, Soriano, LD, Fernández, S, Giménez, S, Lleó, A, Lynch, L, Mccallion, P, Mulryan, N, Pertierra, L, Rebillat, A, Rodríguez-Baz, I, Hernández, AS, Vaqué-Alcázar, L, Videla, L, Wormald, A, Fortea, J, McGlinchey, E. Factors impacting survival in individuals with Down syndrome-associated Alzheimer's disease. ALZHEIMERS & DEMENTIA. 2026; 22(2)DOI:10.1002/alz.71156. PMID:41700075. IF:11.100(Q1/1D).

Guerrero-Zotano, A, Antolin, S, Martorell, AT, Cruz-Jurado, J, Andres, R, Saura, S, Rodriguez-Sanchez, C, Galve, E, Falo, C, Margeli-Vila, M, Rodriguez-Lescure, A, Miguel, A, Chacon, J, Adrover-Cebrian, E, Corbellas-Aparicio, M, Marin-Alcala, M, Gonzalez-Maeso, I, Varela-Ferreiro, S, Arqueros, C, Anton-Torres, A, Servitja, S, Moreno-Munoz, D, Merino, M, Ballesteros-Garcia, A, Echarri-Gonzalez, M, Alonso-Romero, J, Seijas, TR, Iranzo-Cruz, V, De la Haba-Rodriguez, J, Guerra, J, Palomar, AL, Illarramendi, MJ, Ortiz, AG, Garcia-Palomo, A, Ruiz-Borrego, M, Villanueva, R, Zazo, S, Jerez-Gilarranz, Y, Rendo, CR, Lizarraga, NA, Ceballos-Lenza, I, Murillo, JL, Figuero, L, Herranz, J, Martin, N, Fernandez-Garcia, D, Lopez, IA, Lopez-Tarruella, S, Todo, FR. Frequency and Prognostic Significance of ESR1 Mutations Post-CDK4/6 inhibitors in ER+/HER2# Metastatic Breast Cancer: Real-World Data from the GEICAM_RegistEM Study. CLINICAL CANCER RESEARCH. 2026; 32DOI:. PMID:. IF:10.200(Q1/1D).